- Home
- GROY vs NPCE Comparison
GROY vs NPCE Comparison
Compare GROY & NPCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GROY
- NPCE
- Stock Information
- Founded
- GROY 2020
- NPCE 1997
- Country
- GROY Canada
- NPCE United States
- Employees
- GROY N/A
- NPCE N/A
- Industry
- GROY
- NPCE Medical Specialities
- Sector
- GROY
- NPCE Health Care
- Exchange
- GROY Nasdaq
- NPCE Nasdaq
- Market Cap
- GROY 231.6M
- NPCE 217.5M
- IPO Year
- GROY 2021
- NPCE 2021
- Fundamental
- Price
- GROY $1.31
- NPCE $9.00
- Analyst Decision
- GROY Strong Buy
- NPCE Buy
- Analyst Count
- GROY 3
- NPCE 7
- Target Price
- GROY $3.58
- NPCE $15.71
- AVG Volume (30 Days)
- GROY 767.5K
- NPCE 119.2K
- Earning Date
- GROY 11-04-2024
- NPCE 11-12-2024
- Dividend Yield
- GROY N/A
- NPCE N/A
- EPS Growth
- GROY N/A
- NPCE N/A
- EPS
- GROY N/A
- NPCE N/A
- Revenue
- GROY $7,764,000.00
- NPCE $76,452,000.00
- Revenue This Year
- GROY $289.17
- NPCE $20.21
- Revenue Next Year
- GROY $102.86
- NPCE $15.04
- P/E Ratio
- GROY N/A
- NPCE N/A
- Revenue Growth
- GROY 197.02
- NPCE 27.00
- 52 Week Low
- GROY $1.17
- NPCE $5.45
- 52 Week High
- GROY $2.21
- NPCE $18.15
- Technical
- Relative Strength Index (RSI)
- GROY 41.46
- NPCE 64.58
- Support Level
- GROY $1.27
- NPCE $8.46
- Resistance Level
- GROY $1.35
- NPCE $10.42
- Average True Range (ATR)
- GROY 0.05
- NPCE 0.90
- MACD
- GROY -0.01
- NPCE 0.18
- Stochastic Oscillator
- GROY 18.42
- NPCE 67.65
About GROY Gold Royalty Corp.
Gold Royalty Corp is a precious metals-focused royalty and streaming company. It offers creative financing solutions to the metals and mining industry. The company's mission is to acquire royalties, streams and similar interests at varying stages of the mine life cycle to build a balanced portfolio offering near, medium and longer-term attractive returns for investors. It has its business as a single operating segment, being the investment in royalty and mineral stream interests.
About NPCE Neuropace Inc.
NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. It derives substantially all its revenue from the sales of RNS System to hospitals facilities (typically Level 4 CECs) that implant RNS System.